What's Behind the Curtain at Eli Lilly?

Virtually every company in the pharmaceutical space has been hit by the patent cliff -- and Eli Lilly (NYSE: LLY  ) is no exception. The company's top line recently took a major hit when its anti-psychotic drug Zyprex lost patent protection, and Lilly will soon face the loss of exclusivity for its multibillion-dollar anti-depression medication Cymbalta.

The best way to offset losses from patent expirations, of course, is to quickly find better drugs through a more efficient process. One way Lilly is trying to accomplish this is by leveraging "open innovation" platforms. In this video, our health care analysts discuss what "open innovation" is and how it can impact Lilly's R&D process over the long term.

While you can certainly make huge gains in biotech and pharmaceuticals, the best investing approach is to choose great companies and stick with them for the long term. In our free report "3 Stocks That Will Help You Retire Rich," we name stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2208632, ~/Articles/ArticleHandler.aspx, 9/15/2014 8:53:03 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement